Non-GAAP Financial Measures
Search documents
Citizens Financial (CFG) - 2025 Q4 - Earnings Call Presentation
2026-01-21 14:00
4Q25 Financial Results January 21, 2026 Forward-looking statements and use of non-GAAP financial measures This document, contains forward-looking statements within the nearing of the Private Securities Libration Reform Act of 1995. Any statement Ltatchical or current tractis i lobving statement. These statements often include the words "believes," "extimates, "intendes, "intends," "plans," "pans," "argets, " intitatives, " probably, "projects, "o l"guidance" or similar expressions or future conditional verb ...
Progress(PRGS) - 2025 Q4 - Earnings Call Presentation
2026-01-20 22:00
Progress Financial Results Q4 2025 Supplemental Information January 20, 2026 Forward Looking Statements This presentation contains statements that are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Progress has identified some of these forward-looking statements with words like "believe," "may," "could," "would," "might," "should," "expect," "intend," "plan," "target," "anticipate" ...
SmartFinancial Announces Results for the Fourth Quarter 2025
Businesswire· 2026-01-20 22:00
1 KNOXVILLE, Tenn.--(BUSINESS WIRE)--SmartFinancial, Inc. ("SmartFinancial" or the "Company"; NYSE: SMBK), today announced net income of $13.7 million, or $0.81 per diluted common share, for the fourth quarter of 2025, compared to net income of $9.6 million, or $0.57 per diluted common share, for the fourth quarter of 2024, and compared to prior quarter net income of $13.7 million, or $0.81 per diluted common share. Operating earnings, which excludes non-recurring income and expenses, net of tax adjustments ...
F.N.B. Corporation Reports Fourth Quarter and Full Year 2025 Earnings
Prnewswire· 2026-01-20 21:30
Total Assets Crossed $50 billion with Multiple Records for Full Year 2025, Including Total Revenue of $1.8 billion, Non-Interest Income of $369 million, EPS of $1.56 and Capital Levels with the Common Equity Tier 1 at 11.4% (estimate) and Tangible Book Value Per Common Share (non-GAAP) Year-over-Year Growth of 13% (All comparisons refer to the fourth quarter of 2024, except as noted) Average loans and leases totaled $35.0 billion, an increase of $1.2 billion, or 3.4%, driven by consumer loan growth of $1.2 ...
Mountain Commerce Bancorp, Inc. Announces Fourth Quarter 2025 Results and Quarterly Cash Dividend
Prnewswire· 2026-01-20 14:00
KNOXVILLE, Tenn., Jan. 20, 2026 /PRNewswire/ -- Mountain Commerce Bancorp, Inc. (the "Company") (OTCQX: MCBI), the holding company for century-old Mountain Commerce Bank (the "Bank"), today announced financial results and related data as of and for the three and twelve months ended December 31, 2025. The Company also announced today that its Board of Directors declared a quarterly cash dividend of $0.07 per common share, its twenty-first consecutive quarterly dividend. The dividend is payable on March 2, ...
AngioDynamics (NasdaqGS:ANGO) FY Earnings Call Presentation
2026-01-14 23:00
Forward looking statements Notice Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements regarding AngioDynamics' expected future financial position, results of operations, cash flows, business strategy, budgets, projected costs, capital expenditures, products, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statement ...
The Cooper Companies (NasdaqGS:COO) FY Earnings Call Presentation
2026-01-14 22:15
Company Overview - CooperCompanies is a leading global medical device company with FY25 revenue of $41 billion[7] - The company's products are sold in more than 130 countries and it has over 15000 employees in 45+ countries[7] - CooperCompanies operates through two business units: CooperVision (CVI) and CooperSurgical (CSI)[7] Financial Performance and Guidance - CooperCompanies' total revenue has more than doubled in the last decade, with a CAGR of 86% from 2015 to 2025[9] - The company provides FY26 revenue guidance of $4299 - $4338 million, with organic growth of 45% - 55%[10] - CooperVision's FY26 revenue guidance is $2900 - $2925 million, with organic growth of 45% - 55%[10] - CooperSurgical's FY26 revenue guidance is $1399 - $1413 million, with organic growth of 4% - 5%[10] - Non-GAAP EPS guidance for FY26 is $445 - $460[10] - The company targets free cash flow of $575 - $625 million for FY26[10] Market Position and Strategy - CooperVision is the 1 contact lens company in the world in terms of wearers[22] - The global soft contact lens market is an $11 billion market growing at 4-5% annually[16, 18] - CooperSurgical is a leading fertility company in the medical device industry, addressing a ~$3 billion global market with 4-6% annual growth[34]
Helios Technologies (NYSE:HLIO) FY Earnings Call Presentation
2026-01-14 16:45
Financial Performance & Outlook - Helios Technologies reported annual sales of $825 million[9] - The company's market capitalization stands at $2.1 billion[9] - Adjusted Free Cash Flow (FCF) conversion for TTM 3Q25 was 223%[38] - Net debt to TTM adjusted EBITDA ratio was 2.4x at the end of 3Q25, compared to 2.8x in the prior-year period[33] Segment Breakdown & Geography - Hydraulics segment accounts for 65% of the company's sales, while Electronics segment contributes 35%[10] - Americas represent 53% of the company's geographic sales, followed by APAC at 24% and EMEA at 23%[11] Capital Allocation & Debt Management - The company prioritizes debt repayment to provide future optionality on capital deployment[33] - Capital expenditures (CapEx) amounted to $6.7 million, representing 30% of sales in 3Q25[38] Strategic Initiatives - The company aims to shorten the cash conversion cycle through improved working capital management[40] - Helios celebrated its 55th anniversary in 2025[17]
Aveanna Healthcare (NasdaqGS:AVAH) Earnings Call Presentation
2026-01-14 12:00
Financial Performance & Guidance - Aveanna's 2025 revenue guidance is in the range of $2425 million to $2445 million[14, 63] - The adjusted EBITDA guidance for 2025 is $318 million to $322 million[14, 63] - The company projects 2026 revenue in the range of $2540 million to $2560 million[70] - The adjusted EBITDA guidance for 2026 is $318 million to $322 million[70] - Q3 2025 revenue was $621.9 million, a 22.2% increase year-over-year[53] - Q3 2025 adjusted EBITDA was $80.1 million, a 67.5% increase year-over-year[53] Segment Performance - Private Duty Services (PDS) revenue for 2025 is $1947 million[28] - Home Health & Hospice (HHH) revenue for 2025 is $239 million[34] - Medical Solutions (MS) revenue for 2025 is $175 million[43] Key Operating Statistics - Aveanna has 366 locations across 38 states[14] - The company employs approximately 29,000 caregivers[14] - Aveanna delivers approximately 45 million homecare hours annually[14]
Viatris (NasdaqGS:VTRS) FY Earnings Call Presentation
2026-01-13 17:00
44th Annual J.P. Morgan Healthcare Conference January 13, 2026 1 Non-GAAP Financial Measures This presentation includes the presentation and discussion of certain financial information that differs from what is reported under accounting principles generally accepted in the United States ("U.S. GAAP"). These non-GAAP financial measures, including, but not limited to, adjusted EBITDA, free cash flow, free cash flow excluding transaction-related costs, and adjusted EPS, are presented in order to supplement inv ...